BOSTON — 908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company, has adopted REBEL at-line media analyzers in their process development to inform and optimize cell culture feed strategies and media design. REBEL provides insights into cell metabolism to enable […]
Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and manufacturing of lipid nanoparticles (LNP) that help deliver mRNA into cells Cytiva and the University of Adelaide are collaborating with BioCina, an Australian-based multi-product biologics contract development and manufacturing organization (CDMO), to expand its facility in […]
AXT is pleased to announce that they have recently installed the first Rigaku CT Lab HX benchtop microCT system in Oceania. The system was installed at one of New Zealand’s largest industrial companies and is their second system installed by AXT. The Rigaku CT Lab HX represents a significant step forward in technology, with this […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suite of Twist’s VHH antibody libraries to be […]
Rigaku is pleased to announce the sale of another XtaLAB Synergy-ED electron diffractometer. The system will be installed at the Department of Chemistry at the University of Copenhagen in a new electron diffraction facility due to open in Autumn 2023. The Rigaku XtaLAB Synergy-ED is the world’s first turnkey electron diffractometer. Developed in collaboration with […]
SOPHiA GENETICS supports The University of Maryland Medical Center to advance their rare disease research BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that the University of Maryland Medical Center (UMMC) is using SOPHiA GENETICS technology to enhance […]
SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Krsnaa Diagnostics, India’s largest diagnostic services provider in radiology and pathology, is live on SOPHiA DDM™ technology. […]
SAN DIEGO, CA – Todaro Robotics, Inc, a leading laboratory automation and robotics company based in San Diego, has achieved a major milestone with its flagship client Abwiz Bio, Inc a company that speeds up the development of high impact monoclonal antibodies with its proprietary phage display technology.The milestone of operating continuously a very complex […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in the field. The achievement is a testament to the growing demand across scientific and clinical research sectors for a fast and efficient immunoassay solution capable of delivering precise, and reliable biomarker analysis. Manufactured under […]
OPHiA DDM™ HRD Solution will help empower clinical researchers to advance cancer research BOSTON and LAUSANNE, Switzerland SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Tel Aviv Sourasky Medical Center (Ichilov), the largest acute care facility in Israel, has chosen to use […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
